The future of OAB treatment: Emerging nerve targets and AI may guide therapy
Howard B. Goldman, MD, FACS, discusses innovations such as tibial nerve stimulation devices, pudendal nerve targeting, and alternative stimulation frequencies.
Howard Goldman, MD, discusses development of the Glean Urodynamics System
Howard B. Goldman, MD, discusses the rationale and development process for the Glean Urodynamics System.
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC